Portman Square Capital’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-56,400
Closed -$953K – 245
2024
Q4
$953K Sell
56,400
-6,600
-10% -$128K 0.03% 221
2024
Q3
$1.28M Hold
63,000
– – 0.05% 261
2024
Q2
$1.42M Hold
63,000
– – 0.05% 256
2024
Q1
$1.65M Sell
63,000
-52,000
-45% -$1.48M 0.05% 214
2023
Q4
$3.63M Sell
115,000
-3,200
-3% -$86.8K 0.08% 230
2023
Q3
$3.32M Buy
118,200
+66,200
+127% +$2.27M 0.08% 236
2023
Q2
$1.92M Buy
+52,000
New +$1.59M 0.05% 249

Other funds holding CC

Portman Square Capital's CC Position: Q4 2024 in Review

Portman Square Capital sold out of Chemours (CC) in Q4 2024, closing a stake of 95,838 shares — an estimated $1.86M sold.

Portman Square Capital first reported a position in CC in Q2 2023 and held it in 6 quarters. The position peaked at $1.95M in Q3 2024. 442 funds tracked by Wall St. Rank hold CC as of Q4 2024.

  • Portman Square Capital reported no remaining Chemours position as of Q4 2024 after selling out during the quarter.
  • Portman Square Capital sold 95,838 Chemours shares in Q4 2024, an estimated $1.86M.
  • Portman Square Capital first reported a position in Chemours in Q2 2023 and held it in 6 quarters.
  • Portman Square Capital's Chemours position peaked at $1.95M in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Chemours as of Q4 2024.

Based on Portman Square Capital's 13F filing for Q4 2024, filed 16 Jan 2025.